Cencora’s Ameer Ali is calling on pharmaceutical supply chain stakeholders to begin building their NDC-12 roadmaps without delay, warning that the transition requires significant preparation. Ali, speaking in the final installment of
More
Pharmaceutical supply chain compliance has long been viewed as a regulatory burden, but that perception is now shifting significantly across the industry. The Drug Supply Chain Security Act, known as DSCSA, set
More
Genentech, a member of the Roche Group, has announced positive results from the Phase III CELESTIMO study evaluating Lunsumio in follicular lymphoma patients. The trial assessed Lunsumio, also known as mosunetuzumab, in
More
Automated cell therapy manufacturing specialist Cellares is joining forces with Taiwanese biotech GenomeFrontier Therapeutics to advance virus-free CAR-T production. The partnership will assess whether GenomeFrontier’s virus-free manufacturing process is compatible with Cellares’
More
HDA’s Kala Shankle is addressing one of the most pressing open questions in pharmaceutical distribution: what national licensure will mean for wholesalers and third-party logistics providers. Shankle, speaking to the biggest unresolved
More
AstraZeneca (AZN) and Daiichi Sankyo have secured a significant victory after their flagship antibody drug conjugate Enhertu was approved for NHS use in England and Wales. The drug value assessor for England
More
DHL has broken ground on a new cold chain hub at Singapore’s Changi Airport, marking a significant expansion of its pharmaceutical logistics capabilities in Asia. The new facility underlines growing demand for
More
Vera Therapeutics (NASDAQ: VERA) has reported promising new phase 3 clinical data showing its treatment Trutakna successfully stabilises kidney function in patients with IgA nephropathy. The results represent a significant milestone for
More
Marken UPS Healthcare Precision Logistics is expanding its Laboratory Advantage service line to address the rising complexity of clinical trials taking place across the globe. Laboratory logistics form the foundation of clinical
More
Bristol Myers Squibb (BMY) and Ono Pharmaceutical have filed a lawsuit against Amgen (AMGN) in Delaware federal court to block a proposed biosimilar of their cancer drug Opdivo. The suit, filed last
More